METHODS: Eosinophils isolated from the blood of healthy donors or allergic patients were stimulated with Df or Der f 1, and their adhesion to recombinant human-intercellular adhesion molecule (ICAM)-1 was measured using eosinophil peroxidase assays. Generation of the eosinophil superoxide anion (O2−) was examined based on the superoxide dismutase-inhibitable reduction of cytochrome C. Eosinophil-derived neurotoxin (EDN) concentrations in cell media were measured by ELISA as a marker of degranulation.
RESULTS: Df or Der f 1 directly induced eosinophil adhesion to ICAM-1, O2−generation, and EDN release. Anti-αM or anti-β2 integrin antibodies or PAR-2 antagonists suppressed the eosinophil adhesion, O2− generation, and EDN release induced by Df or Der f 1. Eosinophils from allergic patients showed higher adhesion to ICAM-1 than those from healthy donors.
CONCLUSIONS: These findings suggested that Df and Der f 1 directly activate eosinophil functions through αMβ2 integrin and PAR-2. Eosinophil activation by HDM may play roles in the aggravation of allergic symptoms, not only in HDM-sensitized patients but also in non-sensitized patients.